With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Generation of CMV-specific CD19 CAR T cells Using Cytokine Capture Followed by Lentiviral Transduction and Expansion||Research Institute at Nationwide Children's Hospital / Dean Lee, MD/PhD||Reach Grants||2019||Ohio|
|Live-Cell Surface Proteomic Characterization of Atypical Teratoid Rhabdoid Tumors Using High Throughout Multi-Color Flow||University of Colorado Denver / Siddhartha S. Mitra, PhD||Crazy 8 Initiative||2019||Colorado|
|Selectively targeting EP300 with small molecules for neuroblastoma (NB) therapy||Dana-Farber Cancer Institute / Jun Qi, PhD & A. Thomas Look, PhD||Innovation Grants||2019||Massachusetts|
|Targeting a Novel Epigenetic Signature in Diffuse Intrinsic Pontine Gliomas||New York University School of Medicine / Danny Reinberg, PhD||Reach Grants||2019||New York|
|A comprehensive public resource for fusion-negative sarcoma sequencing data||University of California San Francisco / Alejandro Sweet-Cordero, MD & Richard Gorlick, MD||Crazy 8 Initiative||2019||California|
|Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma||Ann & Robert H. Lurie Children's Hospital of Chicago / Oren Becher, MD & Robert Wechsler-Reya, MD||Innovation Grants||2019||Illinois|
|Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells||Stanford University School of Medicine / Alice Bertaina, MD/PhD||Reach Grants||2019||California|
|Targeting Fusion-driven Sarcomas||National Institutes of Health / Javed Khan, MD||Crazy 8 Initiative||2019||Maryland|
|Role of the macro lncRNA KCNQ1OT1 in embryonal rhabdomyosarcoma tumorigenesis||Duke University / Corinne Linardic, MD/PhD & Yarui Diao, MD/PhD||Innovation Grants||2019||North Carolina|
|Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma||City of Hope National Medical Center / Linda Malkas, PhD||Reach Grants||2019||California|